ABIO-8K-20161006

Company

Oruka Therapeutics, Inc.

Filed

October 6, 2016

Period of Report

October 6, 2016

Accession Number

0001564590-16-025688

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →